![Amy Grekowicz Parker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy Grekowicz Parker currently works at Erasca, Inc., as Senior Vice President-Clinical Operations from 2022.
Ms. Parker also formerly worked at Oncternal Therapeutics, Inc., as Vice President-Clinical Operations.
Ms. Parker received her graduate degree from San Diego State University and undergraduate degree from the University of California San Diego.
| Unternehmen | Position | Beginn |
|---|---|---|
| ERASCA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 25.05.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Erasca, Inc.
 Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
Oncternal Therapeutics, Inc.
 Oncternal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that manufactures pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
